Are antibiotics recommended for the management of medication-related osteonecrosis of the jaw (MRONJ) in stages 1, 2, and 3?

Antibiotics are integral in MRONJ management, particularly for stages 2 and 3 where infection is more pronounced. Their use in stage 1 is limited to cases with evident infection or progression risk, underlining a need for individualized treatment plans.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-02
DOI
https://doi.org/10.5281/zenodo.23878250
Primary Topic
Bone health and treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Are antibiotics recommended for the management of medication-related osteonecrosis of the jaw (MRONJ) in stages 1, 2, and 3?

Tripdatabase
4 links
Zenodo (CERN European Organization for Nuclear Research)
Bone health and treatments
article

Are antibiotics recommended for the management of medication-related osteonecrosis of the jaw (MRONJ) in stages 1, 2, and 3?

Tripdatabase
article en

Abstract

Antibiotics are integral in MRONJ management, particularly for stages 2 and 3 where infection is more pronounced. Their use in stage 1 is limited to cases with evident infection or progression risk, underlining a need for individualized treatment plans.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Openalex Percentile: Top 18%
Bone health and treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
Are antibiotics recommended for the management of medication-related osteonecrosis of the jaw (MRONJ) in stages 1, 2, and 3? — Tripdatabase · Zenodo (CERN European Organization for Nuclear Research) (2026) | TGRS Research Map | TGRS